Hikma Pharmaceuticals PLC (Hikma, Group), today announces that its subsidiary Hikma Pharmaceuticals USA Inc. (formerly known as West-Ward Pharmaceuticals Corp.; “Hikma”) is voluntarily extending its previously-announced recall of certain lots (listed below) of Ketorolac Tromethamine Injection USP 30
FDA is strengthening existing warnings about serious behavior and mood-related changes with montelukast (Singulair and generics), which is a prescription medicine for asthma and allergy.
Ante COVID-19: Ministerio de Salud gira instrucciones a iglesias
3 de marzo 2020. En aras de proteger a las congregaciones religiosas y grupos organizados de las distintas iglesias, el Ministro de Salud, Daniel Salas, giró oficios para el arzobispo José Rafael Quirós…